News
Medical societies advise on vitamin D in midst of COVID-19
July 13, 2020
Preliminary results show for the first time that vitamin D intake may be tied to decreased risk for immunotherapy-induced colitis in patients with melanoma.
News
Hyperglycemia predicts COVID-19 death even without diabetes
July 13, 2020
This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.
News
Delayed diagnoses seen in children during COVID-19
July 9, 2020
"Pediatricians on the frontline know what to expect with diabetes. Those children who would have come in late prior to the pandemic are now arriving very late."
News
Captopril questioned for diabetes patients in COVID-19 setting
July 2, 2020
Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers, a new study suggests.
News
Cushing’s and COVID-19: Nontraditional symptoms keys to assessment, treatments
July 2, 2020
Features of Cushing’s syndrome may confound diagnosis and treatment of COVID-19, and also could make patients more susceptible to the pandemic.
![1]()
News
Canagliflozin protects diabetic kidneys
July 1, 2020
Do sodium-glucose cotransporter 2 (SGLT2) medications protect at-risk kidneys in type 2 diabetics?
![1]()
News
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
June 26, 2020
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early speculation, diuresis may be off the list.
News
Cortisol levels on COVID-19 admission may be a marker of severity
June 23, 2020
Those with COVID-19 do appear to mount a stress response to the infection, and cortisol levels on admission to hospital can help determine the prognosis, say UK researchers.
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
June 22, 2020
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.
![1]()
News
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
June 16, 2020
In the landmark DAPA-HF trial that enrolled HFrEF patients without diabetes, treatment with dapagliflozin cut incident type 2 diabetes by a relative 32%.
